Total Funding
62
83
Total FundingPost-IPO Debt raised
Growth Score 62 in past quarter
-12 pts
Heat Score 83 in past quarter
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
18236
Gelteq is a leader in ingestible gel technology for healthcare, nutrition & sport.
James Pekarsky: Chief Financial OfficerPast Role: BioPharmX, Chief Executive Officer- Nathan Givoni: CEO and Co-Founder
About the Company
Gelteq is a biotechnology company specializing in the formulation, development, and manufacturing of ingestible gel-based delivery systems for pharmaceuticals, nutraceuticals, pet care, and sports nutrition. The company's proprietary gel technology aims to enhance oral delivery by addressing challenges such as swallowing difficulties and
improving absorption rates.